GENEWAKE GMBH - Germany 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2013 0 11.978.131 948.643 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ALMA CONSULTING GROUP SAS1
CENTRE ANTICANCEREUX LEON BERARD1
DAACRO GMBH & CO KG1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
FUNDACIO MUTUA DE TERRASSA PER A LA DOCENCIA I RECERCA BIOMEDICA I SOCIAL FUNDACIO PRIVADA CATALANA1
FUNDACION VASCA DE INNOVACION E INVESTIGACION SANITARIAS1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O1
INNATE PHARMA S A1
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT1
POLYGENE1
STICHTING VUVUMC1
THE PROVOST FELLOWS FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN1
THE UNIVERSITY OF TEXAS SYSTEM1
UNIVERSITAET BASEL1
UNIVERSITAET REGENSBURG1
UNIVERSITAETSKLINIKUM AACHEN1
UNIVERSITAETSKLINIKUM HEIDELBERG1
UNIVERSITE DE LAUSANNE1
UNIVERSITY OF BIRMINGHAM1
UNIVERSITY OF SOUTHAMPTON1
UNIVERSITY OF SZEGED1
UNIVERSITY OF TURKU1
VARIONOSTIC1

Constancy:

Total number of partners: 23
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 23
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2013-09-01Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing FEMNAT-CDparticipant5.999.24117
2013-09-01Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers TUMADORparticipant5.978.8908